14 completed, 2 not yet recruiting, 2 terminated, 1 recruiting. 20 Phase 2, 8 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 20 | Completed 14, Not yet recruiting 2, Terminated 2, Recruiting 1, Unknown 1 |
| Phase 1 | 8 | Completed 5, Not yet recruiting 1, Recruiting 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Chronic Pancreatitis: new trials by email Literature Review of Chronic Pancreatitis trials Research Report on Chronic Pancreatitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pirfenidone as Treatment of Chronic Pancreatitis Pirfenidone 267 mg Oral Tablet, Placebo, PROMIS-Global Health - Chronic Pancreatitis | Phase 2 | Not yet recruiting | Vikas Dudeja | 60 | 2026-08-01 | 2026-08-10 |
| A Surgical Procedure (Total Pancreatectomy) With a Transplant Procedure (Islet Cell Autotransplantation) for the Treatment of Chronic Pancreatitis and Benign Pancreatic Tumors Pancreatectomy, Quality-of-Life Assessment, Treatment Planning - Benign Pancreatic Neoplasm, Chronic Pancreatitis | Phase 1 / Phase 2 | Not yet recruiting | OHSU Knight Cancer Institute | 12 | 2026-07-01 | 2025-11-25 |
| Soy Tomato Juice to Improve Outcomes in Pancreatitis Soy-tomato juice product, Will include a soy-tomato juice product to be consumed during the 4 week intervention phase. A total of about 12 ounces (administered in two small cans) of the juice will be consumed - Recurrent Acute Pancreatitis, Chronic Pancreatitis | Phase 1 / Phase 2 | Recruiting | Ohio State University | 35 | 2026-04-02 | 2026-10-20 |
| Intravenous Lidocaine for Pain Associated With Pancreatic Cancer and Chronic Pancreatitis Lidocaine IV - Pancreatic Cancer, Chronic Pancreatitis | Phase 2 | Completed | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 30 | 2021-01-14 | 2023-10-02 |
| Spinal Cord Stimulation for the Treatment of Pain in Chronic Pancreatitis Spinal Cord Stimulation, Sham - Chronic Pancreatitis, Chronic Pain | Phase 2 | Completed | Aalborg University Hospital | 16 | 2020-11-01 | 2024-01-30 |
| Trial of Indomethacin in Chronic Pancreatitis Indomethacin, Placebo, Endoscopy for Pancreatic Function Testing - Chronic Pancreatitis | Phase 1 / Phase 2 | Completed | Mayo Clinic | 27 | 2020-07-15 | 2024-09-04 |
| Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT Hydroxychloroquine, Placebo - Chronic Pancreatitis, Insulin Dependent Diabetes | Phase 2 | Completed | The Cleveland Clinic | 9 | 2017-10-03 | 2022-04-08 |
| A Phase IIa Study With Escalating Dose of MS1819-SD MS1819-SD - Chronic Pancreatitis, Distal Pancreatectomy | Phase 2 | Completed | AzurRx SAS | 11 | 2017-01-27 | 2018-09-28 |
| Alpha-1 Antitrypsin (AAT) Enhances Islet Autograft Survival in Patients With Chronic Pancreatitis Prolastin-C, Placebo - Chronic Pancreatitis | Phase 1 / Phase 2 | Completed | Medical University of South Carolina | 48 | 2017-01-11 | 2023-06-29 |
| Fat Malabsorption in Chronic Pancreatitis Creon36™ - Chronic Pancreatitis | Phase 2 | Completed | Children's Hospital of Philadelphia | 48 | 2016-10-13 | 2019-05-03 |
| A Dose Ranging Study Evaluating Efficacy and Safety of NI-03 NI-03, Placebo - Chronic Pancreatitis | Phase 1 / Phase 2 | Completed | Kangen Pharmaceuticals, Inc | 264 | 2016-02-24 | 2022-12-16 |
| Carbon Monoxide-Saturated Medium for Islet Isolation Carbon monoxide-bubbled mediums - Chronic Pancreatitis | Phase 1 / Phase 2 | Completed | Medical University of South Carolina | 16 | 2015-01-01 | 2019-01-04 |
| Pancreatic Perfusion Using Secretin and MRI Secretin - Chronic Pancreatitis | Phase 1 / Phase 2 | Unknown | University of Nottingham | 15 | 2012-06-01 | 2016-02-18 |
| Efficacy Study of Δ9-THC to Treat Chronic Abdominal Pain Namisol, Diazepam - Cannabinoid, Tetrahydrocannabinol | Phase 2 | Completed | Radboud University Medical Center | 24 | 2011-10-01 | 2013-07-09 |
| Secretin Infusion for Pain Due to Chronic Pancreatitis Human Secretin - Chronic Pancreatitis | Phase 1 / Phase 2 | Completed | ChiRhoClin, Inc. | 12 | 2010-12-01 | 2016-03-09 |
| Safety And Efficacy Of Tanezumab In Patients With Chronic Pancreatitis Tanezumab, Placebo - Chronic Pancreatitis | Phase 2 | Terminated | Pfizer | 2 | 2010-10-13 | 2021-03-23 |
| BreathID® Test: A Non-invasive Modality to Detect Pancreatic Exocrine Insufficiency benzoyl-L-tyrosyl-[1-13C]alanine (Bz-Tyr-Ala) - Chronic Pancreatitis, Healthy Volunteers | Phase 2 | Completed | Meridian Bioscience, Inc. | 33 | 2009-01-01 | 2022-12-20 |
| Chronic Pancreatitis. Effect of Pioglitazone on Endocrine Function, Exocrine Function & Structure, Pain & Life Quality Pioglitazone, Placebo - Chronic Pancreatitis, Insulin Resistance | Phase 2 | Completed | University of Michigan | 64 | 2008-11-01 | 2018-01-11 |
| Pain and Chronic Pancreatitis - Clinical End Experimental Studies Pregabalin, placebo - Chronic Pancreatitis | Phase 2 / Phase 3 | Completed | Aalborg University Hospital | 64 | 2008-10-01 | 2010-08-20 |
| Safety and Efficacy Study of Thalomid in Patients With Chronic Pancreatitis Thalidomide - Chronic Pancreatitis | Phase 2 | Terminated | Winthrop University Hospital | 10 | 2005-08-01 | 2008-01-16 |
Pancreatitis, Chronic (20) · Pancreatitis (7) · Abdominal Pain (2) · Exocrine Pancreatic Insufficiency (2) · Pain (2) · Bronchiolitis Obliterans Syndrome (1) · Chronic Pain (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 1 (1) · Inflammation (1) · Insulin Resistance (1) · Neuralgia (1) · Pancreatic Neoplasms (1) · alpha 1-Antitrypsin Deficiency (1)
Chronic Disease (20) · Digestive System Diseases (20) · Disease Attributes (20) · Pancreatic Diseases (20) · Pathologic Processes (20) · Pathological Conditions, Signs and Symptoms (20) · Pancreatitis (13) · Neurologic Manifestations (4) · Signs and Symptoms (4) · Endocrine System Diseases (2) · Glucose Metabolism Disorders (2) · Immune System Diseases (2) · Lung Diseases (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2)
Secretin (2) · Diazepam (1) · Dronabinol (1) · Endoscopy (1) · Hydroxychloroquine (1) · Indomethacin (1) · Pancreatectomy (1) · Pancrelipase (1) · Pioglitazone (1) · Pregabalin (1) · Sodium Chloride (1) · Spinal Cord Stimulation (1) · Tablets (1) · Thalidomide (1) · benzoyl-tyrosyl-alanine (1)
Aalborg University Hospital (2) · Medical University of South Carolina (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · AzurRx SAS (1) · ChiRhoClin, Inc. (1) · Children's Hospital of Philadelphia (1) · Kangen Pharmaceuticals, Inc (1) · Mayo Clinic (1) · Meridian Bioscience, Inc. (1) · OHSU Knight Cancer Institute (1) · Ohio State University (1) · Pfizer (1) · Radboud University Medical Center (1) · The Cleveland Clinic (1) · University of Michigan (1)
United States (11) · Netherlands (3) · Denmark (2) · Australia (1) · France (1) · India (1) · New Zealand (1) · Russia (1) · Ukraine (1) · United Kingdom (1)
Hongjun Wang, Ph.D (2) · Babette Zemel, PhD (1) · Betul Hatipoglu, MD (1) · Brett C Sheppard (1) · Harry van Goor, MD PhD (1) · Helga A Gulisano, MD (1) · James H Grendell, MD (1) · John Simpson (1) · Marc G. Besselink, MD PhD MSc (1) · Matthew DiMagno, M.D. (1) · Phiip Hart, MD (1) · Santhi Vege, MD (1) · Timothy B Gardner, M.D. (1)
PMID 21848870, PMID 22879908, PMID 23548879, PMID 31412955, PMID 38103842, PMID 38659255, PMID 40622408
R01DK105183 (1), R01DK138871 (1), R21AA017271 (1), R21DK117212 (1)